Clinical and electromyographic follow-up of patients taking riluzole and lithium carbonate - A randomized controlled trial
Phase 2
- Conditions
- Amyotrophic Lateral SclerosisC10.228.854.139
- Registration Number
- RBR-2n5mtq
- Lead Sponsor
- Secretaria de Estado de Saúde do Distrito Federal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruitment completed
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Age over 18 years; no upper limit;
Disease diagnosis Motor Neuron possible, probable or definite;
Exclusion of other diseases by MRI skull and marrow and electromyography;
Forced Vital Capacity over 50%.
Size of the target sample:100
Exclusion Criteria
FVC less than 50%
other diseases exclusion
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method